Skip Navigation


European Heart Journal Advance Access originally published online on December 8, 2006
European Heart Journal 2007 28(8):996-1003; doi:10.1093/eurheartj/ehl364
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/8/996    most recent
ehl364v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Pérez-Gómez, F.
Right arrow Articles by Fernández, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pérez-Gómez, F.
Right arrow Articles by Fernández, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Antithrombotic therapy in elderly patients with atrial fibrillation: effects and bleeding complications: a stratified analysis of the NASPEAF randomized trial

Francisco Pérez-Gómez1,*, Jose A. Iriarte2, Javier Zumalde3, Jesus Berjón4, Antonio Salvador5,6, Eduardo Alegría7, María P. Maluenda8, Susana Asenjo9, Rosario Perez-Saldaña10, Ricardo Gómez de la Torre11, Ramón Bover12 and Cristina Fernández13

1 Section of Cardiology, Instituto Cardiovascular, Hospital Universitario San Carlos, Madrid, Spain
2 Anticoagulation Unit, Hospital Basurto, Bilbao, Spain
3 Department of Cardiology, Hospital Galdakao, Bilbao, Spain
4 Department of Cardiology, Hospital de Navarra, Pamplona, Spain
5 Department of Cardiology, Hospital Dr. Peset, Valencia, Spain
6 Department of Cardiology, Hospital La Fe, Valencia, Spain
7 Section of Cardiology, Clínica Universitaria, Pamplona, Spain
8 Anticoagulation Unit, Hospital San Carlos, Madrid, Spain
9 Anticoagulation Unit, Hospital San Carlos, Madrid, Spain
10 Anticoagulation Unit, Centro Medico, Avenida Portugal, Madrid, Spain
11 Department of Medicine, Hospital San Agustín, Avilés, Spain
12 Instituto Cardiovascular, Hospital San Carlos, Madrid, Spain
13 Epidemiological and Research Unit, Hospital San Carlos, Madrid, Spain

Received 28 June 2006; revised 9 October 2006; accepted 19 October 2006; online publish-ahead-of-print 8 December 2006.

* Corresponding author. Tel: +34 91 3303149; fax: +34 91 3303142. E-mail address: fperezg.hcsc{at}salud.madrid.org

See page 926 for the editorial comment on this article (doi:10.1093/eurheartj/ehm077)

Aims: Atrial fibrillation patients with prior embolism have a high risk of vascular events in spite of anticoagulant therapy and elderly patients carry an additional risk. We analysed and compared vascular events-rate between older and younger than 75 years atrial fibrillation patients randomized to anticoagulant-alone or combined antiplatelet plus moderate-level anticoagulant therapy.

Methods and results: A total of 967 patients stratified by age and the history of prior embolism were randomized to therapeutic doses of anticoagulant-alone or combined antithrombotic therapy. Primary events were fatal and non-fatal ischaemic or haemorrhagic stroke/transient ischaemic attack, systemic embolism and myocardial infarction, sudden death and death from bleeding. The elderly, compared with the younger patients, had higher event-rate [hazard ratio 2.31 (95% confidence interval 1.37–3.90), P < 0.003]. The elderly suffered higher severe bleeding event-rate during anticoagulant therapy. The combined, compared with the anticoagulant therapy, reduced the vascular events-rate in the elderly (P = 0.012) and caused less intracranial haemorrhages and less bleeding mortality, although more non-fatal gastric bleeding.

Conclusion: The elderly with AF had a higher event-rate than the younger patients. A higher severe bleeding event-rate was also registered in elderly patients receiving anticoagulant therapy. Combined, compared with anticoagulant therapy, significantly reduced vascular events and bleeding mortality in elderly patients.

Key Words: Atrial fibrillation • Stroke • Haemorrhages • Elderly • Anticoagulation • Antiplatelets


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Stroke prevention in atrial fibrillation: antiplatelet therapy revisited
Gregory Y.H. Lip and Timothy Watson
EHJ 2007 28: 926-928. [Extract] [Full Text]  





Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.